rs1553396458
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP2PP3_ModeratePP5
The NM_001615.4(ACTG2):c.632G>A(p.Arg211Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000139 in 1,440,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R211L) has been classified as Pathogenic.
Frequency
Consequence
NM_001615.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACTG2 | NM_001615.4 | c.632G>A | p.Arg211Gln | missense_variant | 7/9 | ENST00000345517.8 | |
ACTG2 | NM_001199893.2 | c.503G>A | p.Arg168Gln | missense_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACTG2 | ENST00000345517.8 | c.632G>A | p.Arg211Gln | missense_variant | 7/9 | 1 | NM_001615.4 | P1 | |
ACTG2 | ENST00000409624.1 | c.632G>A | p.Arg211Gln | missense_variant | 8/10 | 2 | P1 | ||
ACTG2 | ENST00000409731.7 | c.503G>A | p.Arg168Gln | missense_variant | 6/8 | 2 | |||
ACTG2 | ENST00000438902.6 | c.*697G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/10 | 5 |
Frequencies
GnomAD3 genomes ? Cov.: 31
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1440226Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 715836
GnomAD4 genome ? Cov.: 31
ClinVar
Submissions by phenotype
Visceral myopathy 1 Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | Insufficient data for genotype-phenotype correlations - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Oct 17, 2016 | - - |
Pathogenic, no assertion criteria provided | case-control | Wangler Lab, Baylor College of Medicine | Oct 04, 2019 | Identified as a de novo event in our clinical cohort of MMIHS - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 28, 2023 | Identified in two individuals from the same family with CIPO or MMIHS (Whittington et al., 2017); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29387497) - |
ACTG2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 28, 2023 | The ACTG2 c.632G>A variant is predicted to result in the amino acid substitution p.Arg211Gln. This variant was reported in an individual with megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) (Table S2 and S3, ID FAM53-1 or Fam53, maternally-inherited, Assia Batzir et al. 2019. PubMed ID: 31769566) and was also reported in an individual with chronic intestinal pseudoobstruction and in her fetus with MMIHS (Whittington et al. 2017. PubMed ID: 29387497). This variant has not been reported in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at